86 related articles for article (PubMed ID: 2353664)
1. A symposium: International update--the important role of aldosterone and aldosterone antagonism in cardiovascular medicine. Based on symposia held in Brussels, Belgium and Newport Beach, California.
Am J Cardiol; 1990 Jun; 65(23):1K-57K. PubMed ID: 2353664
[No Abstract] [Full Text] [Related]
2. [Aldosterone blockade in essential hypertension].
Venco A; Grandi AM
Ital Heart J; 2005 May; 6 Suppl 1():34S-42S. PubMed ID: 15945298
[TBL] [Abstract][Full Text] [Related]
3. [Aldosterone blocking -- a rediscovered therapy principle].
MMW Fortschr Med; 2003 Oct; 145(44):43. PubMed ID: 14655507
[No Abstract] [Full Text] [Related]
4. Adverse cardiorenal effects of aldosterone: is aldosterone antagonism beneficial?
Coca SG; Perazella MA
Expert Rev Cardiovasc Ther; 2005 May; 3(3):497-512. PubMed ID: 15889977
[TBL] [Abstract][Full Text] [Related]
5. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
Dieterich HA; Wendt C; Saborowski F
Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159
[TBL] [Abstract][Full Text] [Related]
7. Proceedings of the symposium Mineralocorticoids in Essential and Secondary Hypertension. Newport Beach, California, February 28, 1982.
Clin Exp Hypertens A; 1982; 4(9-10):1447-934. PubMed ID: 7139969
[No Abstract] [Full Text] [Related]
8. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension.
Mahmud A; Feely J
Am J Hypertens; 2005 Jan; 18(1):50-5. PubMed ID: 15691617
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone antagonists: effective add-on therapy for the treatment of resistant hypertension.
Gaddam KK; Pratt-Ubunama MN; Calhoun DA
Expert Rev Cardiovasc Ther; 2006 May; 4(3):353-9. PubMed ID: 16716096
[TBL] [Abstract][Full Text] [Related]
10. [Profibrotic effects of aldosterone].
Van Den Meiracker AH; Huizenga AT; Boomsma F
Ned Tijdschr Geneeskd; 2004 Jul; 148(31):1532-6. PubMed ID: 15366722
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone receptor antagonism in heart failure.
Jennings DL; Kalus JS; O'Dell KM
Pharmacotherapy; 2005 Aug; 25(8):1126-33. PubMed ID: 16207104
[TBL] [Abstract][Full Text] [Related]
12. [Effect of aldosterone antagonism in heart failure: pharmacotherapeutic options].
Diercks GF; Overdiek JW; van Veldhuisen DJ
Ned Tijdschr Geneeskd; 2001 Feb; 145(5):204-8. PubMed ID: 11219145
[TBL] [Abstract][Full Text] [Related]
13. Aldosterone and cardiovascular disease.
Gaddam KK; Pimenta E; Husain S; Calhoun DA
Curr Probl Cardiol; 2009 Feb; 34(2):51-84. PubMed ID: 19135616
[TBL] [Abstract][Full Text] [Related]
14. Should we consider aldosterone as the primary screening target for preventing cardiovascular events?
Francis GS; Tang WH
J Am Coll Cardiol; 2005 Apr; 45(8):1249-50. PubMed ID: 15837257
[No Abstract] [Full Text] [Related]
15. Optimization of beta-blockers for cardiovascular care. International Bisoprolol Symposium. Rabat, Morocco, November 20-22, 1985.
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S1-174. PubMed ID: 2439778
[No Abstract] [Full Text] [Related]
16. Aldosterone antagonists in congestive heart failure.
Soberman J; Chafin CC; Weber KT
Curr Opin Investig Drugs; 2002 Jul; 3(7):1024-8. PubMed ID: 12186262
[TBL] [Abstract][Full Text] [Related]
17. Use of aldosterone antagonists in resistant hypertension.
Calhoun DA
Prog Cardiovasc Dis; 2006; 48(6):387-96. PubMed ID: 16714158
[TBL] [Abstract][Full Text] [Related]
18. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure.
Bauersachs J; Fraccarollo D
Minerva Cardioangiol; 2003 Apr; 51(2):155-64. PubMed ID: 12783071
[TBL] [Abstract][Full Text] [Related]
19. Aldosterone and cardiovascular pathology: from bench to bedside.
Vintilă M; Băluţă M
Rom J Intern Med; 2004; 42(1):15-26. PubMed ID: 15529592
[TBL] [Abstract][Full Text] [Related]
20. Resistant hypertension and aldosterone excess: new insights from ambulatory blood pressure monitoring.
Grassi G; Whitworth JA
J Hypertens; 2007 Oct; 25(10):2006-7. PubMed ID: 17885540
[No Abstract] [Full Text] [Related]
[Next] [New Search]
